Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StopCMV: Sirolimus for CMV Recurrence in Kidney Transplant
NCT02671318Phase 4Unknown
- Sponsor
- Hospital do Rim e Hipertensão
- Start
- Sep 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in cytomegalovirus infection (CMV) (2 arms), sponsored by Hospital do Rim e Hipertensão. Primary endpoint: Cytomegalovirus infection/disease recurrence at 1 year. Status: unknown.
02
Drugs
sirolimus
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT02671318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02671318.